GCG and dementia: Drugs considered for repurposing in dementia obtained from ClinicalTrials.gov target tyrosine kinases, retinoid X receptors, glucagon-like peptide 1 (GLP-1), peroxisome proliferator-activated receptor-γ (PPARγ), calcium channel, angiotensin receptors and phosphodiesterases (Table 2).